NCT02061267View on ClinicalTrials.gov

Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2015

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Niacin

The subjects will receive a vitamin B3 supplement (2 g)

DIETARY_SUPPLEMENT

Saturated meal

Test meal with high-fat (containing 72% saturated fat, 22% carbohydrate, and 6% protein)

DIETARY_SUPPLEMENT

Monounsaturated meal

Test meal with high-fat (containing 72% monounsaturated fat, 22% carbohydrate, and 6% protein)

DIETARY_SUPPLEMENT

Polyunsaturated meal

Test meal with high-fat (containing 72% polyunsaturated omega-3 fat, 22% carbohydrate, and 6% protein)

Trial Locations (1)

41012

Instituto de la Grasa, CSIC, Seville

Sponsors
All Listed Sponsors
lead

National Research Council, Spain

OTHER_GOV

NCT02061267 - Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome | Biotech Hunter | Biotech Hunter